Get started

Medianline

Carvana's Fundamentals And Chart Screeming For A ShortFrom a very well known Short-Seller in the markets I read a concerning letter this morning: "Carvana Trades At An 845% Higher Sales Multiple Than Online Car Peers Like CarMax and AutoNation, And A 754% Premium On A Forward Earnings Basis." ...ummmhh... §8-() The Chart does look very scary too. This exponential move can't sustain very long. As we see, the first bounce already alerts me to prepare for a big short. If this plays out as projected, we see a heavy dump in the coming weeks and months.
NYSE:CVNAShort
by Tr8dingN3rd
NVDA - Back again, now down again?The pattern seems to repeat. Again, we had a HAGOPIAN, which sais, that price goes back more than from where it came, and this rule was right. Up in here, I'm not that confident anymore that price will reach the Centerline. But, it's not about what I think, or how confident I'm are. I just have to follow my Strategy and act according to the Rules, the trading framework of the Medianlines. That said, we either shoot up on earnings, or we definitely tank down. For now, there is no trade, only a Gamble. I rarely gamble, so I'll sit on the sidelines and let it happen whatever will come out on earnings. As for a Lotto-Ticket, I would buy some Puts and just have fun to watch how they get burned, or how I get a Christmas Moment in the beginning of the new year §8-)
NASDAQ:NVDAShort
by Tr8dingN3rd
2
Can Pain Be Managed Without Addiction?Vertex Pharmaceuticals has achieved a monumental breakthrough in pain management, securing FDA approval for Journavx, the first new class of painkiller in over 20 years. This non-opioid drug introduces a paradigm shift, targeting pain signals directly at the source without the addictive risks associated with traditional analgesics. The significance of this development cannot be overstated, as it promises a new era where acute pain can be treated effectively and safely, potentially altering the landscape of medical treatment for millions. Journavx operates by selectively inhibiting NaV1.8, a sodium channel vital for pain signaling, thus preventing pain signals from reaching the brain. This mechanism not only offers relief but does so without the side effects that have long plagued opioid use. The implications for healthcare are profound, offering doctors and patients alike a tool that can redefine how we approach pain management in clinical settings. Vertex's success with Journavx showcases the company's commitment to pioneering treatments that address some of the most pressing needs in modern medicine. Financially, this approval has bolstered Vertex's market position, evidenced by a significant uptick in stock performance following the announcement. With a revenue projection for 2025 set between $11.75 and $12.0 billion, Vertex is not just riding the wave of this single approval but is also expanding its therapeutic horizons. The strategic leadership transitions announced alongside this approval signal a robust plan for future innovation, challenging investors and healthcare professionals to think about the evolving landscape of drug development and patient care.  This moment invites us to ponder the future of pharmaceuticals - one where efficacy does not compromise safety, where innovation in treatment could lead to broader societal benefits by reducing dependency on addictive substances. Vertex's journey with Journavx might just be the beginning of a new chapter in medical science, urging us to envision a world where pain management is humane and humane-centered.
NASDAQ:VRTXLong
by UDIS_View
Coffee KC - Why I see $390 and $470 as possibleThe Medianlines project the most probable path of price. It's not a fortunetelling tool. It's a technical tool which is based on serious statistical research. So, what I do when I use it is, using statistical proven evidence on a graphical basis, supported by a definite trading framework. Why do I pound on these information? Because it's important to understand what Medianlines aka Pitchforks are based off, and what they are good for in trading. No "Magic", just a tool that helps a trader/TA in it's daily Job. ANALYSIS OF COFFEE The up-sloping white Fork shows us the most probable path of price. It's up. Price blew through the Center-Line, found support, and advanced even more to the upside from there. Then we have the slanted yellow dashed lines. What are they? Many say this is a action/reaction thingy. Others say, it's a timing tool. I say, it's both. The way I use it, it takes in the angle from the last real high, and the low of the pullback from it. Then I go back to the last low before the new high. This creates an Angle, and a width. Combined it gives us not only a potential timing, but with the dynamic of price movement also potential resistance/support. So, we can see where we got such signals - where the orange circles are. The second one intersects very nicely with the Center-Line of the white Fork. I observe this "incident" often when I use them. Back to Coffee...BRB §8-) We see the time/price line intersecting with the 1/4 line of the Fork. I expect a reaction there - even a pullback back to the Center-Line is possible from there. But if price also blows through this level, then I know that the next Target will be the Upper-Medianline-Parallel. So, there we have it. I hope you can take away some knowledge from this post and thanks for all the boosting and following folks.
ICEUS:KC1!Long
by Tr8dingN3rd
5
Crude Oil Is SandwichedPrice is currently between the white centerline and the long-term support/resistance level. Since the price is near the centerline, we're seeing a kind of pullback to it. According to the Medianline framework, this is expected after trading below it. The downside target would be the orange CL, as that aligns with the organic target. However, between the current price and the CL target, the long-term support level is quietly sitting there—possibly waiting to trap shorts. What should a trader do now? a) We could stay on the sidelines, observe, and learn. b) We could go short, reasoning that the price is trading below the white CL and has made a textbook pullback to it. My stop would be placed above the orange bar that broke through the white CL. A long position is not an option for me, as we are still below the white CL. By the way: Look to the left and notice how the current situation mirrors past price action: 1. Break below the CL 2. Retest the CL 3. Move downward
NYMEX:CL1!Short
by Tr8dingN3rd
DAX - Bullseye! Next Act: The Decline?Whenever the markets are booming, whenever a gardener starts giving stock recommendations, it’s time to brace yourself… The German Dax has reached it's Centerline. It's back in Balance - Or has reached it's extreme, depending on how you look at it. Whenever this happens, we the Market a) turns and trades in the opposite direction towards the next LIne. In this case the Lower-Medianline-Parallel. or b) trades through it, most of the time comes back to it, and continues in the origianl direction, which in this case would be up. To me, this is the time to watch the DAX more closely. If you are a follower, you now that I have a Bias - which is not always helpful in my trading. But yes, I tend to lean to the short side. Specially in these over hyped, over invested times. So I stalk a short, but in the same time be open for a long after a confirmation on the daily time-frame. Let's see, let's be patient and don't listen to your gardener... 🌱👨‍🌾 🌿👩‍🌾
XETR:DAXShort
by Tr8dingN3rd
MSTR - Back to a new short levelAfter hitting Profit Target 1 (PTG1), it’s time to make a decision about the remaining position. The fact is, MSTR tested the 1/4 level for the second time and found solid support there. Now we’ve moved higher, back to the centerline. For me, it’s clear: if we get an Open and Close — a full bar — above the CL, I’ll close the rest of my short position. I still think MSTR is heavily manipulated. Besides the fact that this Bitcoin catalyst isn’t following BTC’s moves the way it should, it’s cheating investors for profits. That said — if there’s weakness, I’ll continue building the position. If I had no position, this is the place where I would open it on a Short trigger. If there’s strength, I’ll close it.
NASDAQ:MSTRShort
by Tr8dingN3rd
3